GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment is a paper indexed in ScholarIQ from OpenAlex.
How many citations does GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment have?
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment has 68 citations in the OpenAlex counts ScholarIQ stores.
When was GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment published?
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment has 2016 year in the ScholarIQ index.
What is the open-access status of GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment?
GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment has gold oa status in the ScholarIQ index.
What is the DOI of GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment?
The DOI for GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment is on the source record.
What is the PMID of GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment?
The PMID for GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment is on the source record.
What is the OpenAlex record for GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment?
The OpenAlex for GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment is on the source record.